Financials
- Market Capitalization 13.53 M
- Employee 1
- Founded N/A
- CEO N/A
- Website www.gtbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG000DHJ738
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4696 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.42 USD | -4.55% | +10.53% | -12.50% | -60.00% | 13.67 M USD | ||
| 4697 | ICU SeaStar Medical Holding Corporation - Common Stock | 3.09 USD | -0.32% | -8.85% | -6.36% | +25.61% | 13.62 M USD | ||
| 4703 | KALA KALA BIO, Inc. - Common Stock | 0.69 USD | -13.75% | -15.85% | 0.00% | -94.25% | 13.34 M USD | ||
| 4706 | PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.13 USD | +0.89% | -5.04% | +16.49% | -5.04% | 13.13 M USD |